857371 | VU0359595
(1R,2R)-N-([S]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxamide
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
Info
VU0359595
(1R,2R)-N-([S]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxamide
VU0359595 has been shown to selectively inhibit the PLD1 isoform at nM levels (see data below).
Data
Yes
No
C25H29BrN4O2
C 60.36%, H 5.88%, Br 16.06%, N 11.26%, O 6.43%
>99%
1 Years
-20°C
CAS Number
1246303-14-9
CAS Registry Number is a Registered Trademark of the American Chemical Society
CAS Registry Number is a Registered Trademark of the American Chemical Society
497.427
496.147
EVJVU0359595
Powered by Bioz
Certificates of Analysis
- Certificate of Analysis (Lot No. 857371P-1MG-A-011 and 5828PGA011)
- Certificate of Analysis (Lot No. 857371P-1MG-B-011 and 5828PGB011)
- Certificate of Analysis (Lot No. 857371P-1MG-C-011 and 5828PGC011)
